Saturday, April 27, 2024 4/27/2024

Biofeedback-Enhanced Treatment for Sensorimotor Learning in Speech Sound Disorders: Clinical Trial and Delineation of Subtypes

Award Number: R01DC017476
ORGANIZATION: NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

Project Summary/Abstract Children with speech sound disorder show diminished intelligibility in spoken communication, with negative con- sequences for both social-emotional and academic-occupational outcomes [1–4]. While most speech deviations resolve by the late school-age years, between 2-5% of speakers exhibit residual speech sound disorder (RSSD) that persists through adolescence or even adulthood [5–7]. Both affected children/families and speech-language pathologists (SLPs) have highlighted the critical need for research to identify more effective forms of treatment for children with RSSD. Our work in the previous funding cycle showed that individuals with RSSD benefit from treat- ment incorporating technologically enhanced sensory feedback (visual-acoustic biofeedback, ultrasound biofeed- back). However, real-world adoption of biofeedback treatment remains limited by equipment costs and lack of access to providers with specialized training. For our next phase of research, we focus on developing methods to support wider implementation of technology-enhanced treatment for RSSD. Specifically, we investigate the possibility that access to biofeedback can be expanded through telepractice service delivery and the use of Artificial Intelligence (AI)-powered technol- ogy to extend the services provided by SLPs. At the same time, we evaluate whether the efficacy of biofeedback can be further enhanced by adopting a precision medicine approach in which a treatment method is selected based on a learner’s individual profile of sensory strengths and weaknesses. In this proposal, we will conduct the first controlled comparison of biofeedback treatment delivered in person versus via telepractice (Aim 1), testing our hypothesis that biofeedback intervention can be delivered remotely without any unacceptable loss of efficacy. If successful, this study will greatly expand the reach of biofeedback by making it easier for children with RSSD to connect with trained clinicians. In Aim 2, we will utilize technology de- veloped in the previous funding cycle to assess whether the maintenance of gains achieved through biofeedback treatment can be enhanced through AI-mediated home practice. Finally, Aim 3 will lay groundwork for a precision medicine approach by testing whether relative response to ultrasound and visual-acoustic biofeedback can be predicted from a learner’s profile of sensory response across auditory and somatosensory domains. While new technologies have the potential to revolutionize the development and delivery of interventions for speech disorders, there is an ongoing need for well-designed research studies to bring these advances into evidence-based clinical practice. This research will address the needs of children with RSSD and the clinicians who treat them by providing a robust evidence base to guide clinical decision-making and user-friendly tools that support implementation.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $672,498 )
2024	2024	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Research Related to Deafness and Communication Disorders	001	6	11/8/2023	COMPETING CONTINUATION	$672,498
2024	2023	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Research Related to Deafness and Communication Disorders	000	5	10/31/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $672,498

Issue Date FY: 2023 ( Subtotal = $695,784 )
2023	2023	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Research Related to Deafness and Communication Disorders	001	5	1/13/2023	NON-COMPETING CONTINUATION	$69,578
2023	2023	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Research Related to Deafness and Communication Disorders	000	5	12/22/2022	NON-COMPETING CONTINUATION	$626,206
														Subtotal = $695,784

Issue Date FY: 2022 ( Subtotal = $742,861 )
2022	2022	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Research Related to Deafness and Communication Disorders	002	4	4/13/2022	NON-COMPETING CONTINUATION	$71,362
2022	2022	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Research Related to Deafness and Communication Disorders	001	4	1/11/2022	SUPPLEMENT FOR EXPANSION	$28,960
2022	2022	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Research Related to Deafness and Communication Disorders	000	4	12/29/2021	NON-COMPETING CONTINUATION	$642,247
2022	2022	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Research Related to Deafness and Communication Disorders	003	4	4/19/2022	SUPPLEMENT FOR EXPANSION	$292
														Subtotal = $742,861

Issue Date FY: 2021 ( Subtotal = $1,025,166 )
2021	2021	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Research Related to Deafness and Communication Disorders	002	3	8/12/2021	SUPPLEMENT FOR EXPANSION	$19,501
2021	2021	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Research Related to Deafness and Communication Disorders	001	3	1/7/2021	NON-COMPETING CONTINUATION	$73,689
2021	2021	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Research Related to Deafness and Communication Disorders	000	3	12/30/2020	NON-COMPETING CONTINUATION	$663,197
2021	2021	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Research Related to Deafness and Communication Disorders	003	3	8/13/2021	SUPPLEMENT FOR EXPANSION	$268,779
														Subtotal = $1,025,166

Issue Date FY: 2020 ( Subtotal = $737,049 )
2020	2020	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Research Related to Deafness and Communication Disorders	000	2	2/4/2020	NON-COMPETING CONTINUATION	$737,049
														Subtotal = $737,049

Issue Date FY: 2019 ( Subtotal = $796,715 )
2019	2019	NEW YORK UNIVERSITY	70 WASHINGTON SQ S	NEW YORK	NY	10012	NEW YORK	USA	Research Related to Deafness and Communication Disorders	000	1	12/26/2018	NEW	$796,715
														Subtotal = $796,715

Grand Total All Awards = $4,670,073

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Biofeedback-Enhanced Treatment for Sensorimotor Learning in Speech Sound Disorders: Clinical Trial and Delineation of Subtypes

Award Number: R01DC017476

ORGANIZATION: NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer